Ms. Holmes and Mr. Balwani were found guilty of defrauding investors by falsely claiming Theranos’ technology could conduct fast, accurate blood tests with just a drop of blood. On Feb. 24, the appeals court ruled that their convictions were valid and that any minor legal errors during the 2022 trial did not affect the overall outcome. Becker’s obtained these court documents.
Ms. Holmes’ lawyers presented her appeal in a California federal appeals court June 11.
With their appeals rejected, Ms. Holmes and Mr. Balwani will remain in prison.
